P

Inventor

STARKE INGEMAR

SE58 patents
⚠️ This page may combine multiple inventors who share the name “STARKE INGEMAR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ALBIREO AB

32 patents
US10487111B2Nov 26, 2019

IBAT inhibitors for the treatment of liver diseases

ALBIREO AB23 citations98
US10093697B2Oct 9, 2018

IBAT inhibitors for the treatment of liver diseases

ALBIREO AB25 citations98
US10011633B2Jul 3, 2018

IBAT inhibitors for the treatment of liver diseases

ALBIREO AB20 citations98
US9694018B1Jul 4, 2017

IBAT inhibitors for the treatment of liver disease

ALBIREO AB47 citations98
US9688720B2Jun 27, 2017

IBAT inhibitors for the treatment of liver diseases

ALBIREO AB27 citations98
US11572350B1Feb 7, 2023

Benzothia(di)azepine compounds and their use as bile acid modulators

ALBIREO AB17 citations95
US11225466B2Jan 18, 2022

Benzothiadiazepine compounds and their use as bile acid modulators

ALBIREO AB23 citations95
US11732006B2Aug 22, 2023

IBAT inhibitors for the treatment of liver diseases

ALBIREO AB11 citations94
US11267794B2Mar 8, 2022

Benzothia(di)azepine compounds and their use as bile acid modulators

ALBIREO AB21 citations94
US11261212B2Mar 1, 2022

IBAT inhibitors for the treatment of liver diseases

ALBIREO AB17 citations94
US11180465B2Nov 23, 2021

Benzothia(di)azepine compounds and their use as bile acid modulators

ALBIREO AB25 citations94
US11111224B2Sep 7, 2021

Benzothia(di)azepine compounds and their use as bile acid modulators

ALBIREO AB30 citations94
US11014898B1May 25, 2021

Benzothiazepine compounds and their use as bile acid modulators

ALBIREO AB30 citations94
US10981952B2Apr 20, 2021

IBAT inhibitors for the treatment of liver diseases

ALBIREO AB20 citations94
US10975045B2Apr 13, 2021

Benzothiazepine compounds and their use as bile acid modulators

ALBIREO AB23 citations94
US10941127B2Mar 9, 2021

Benzothiadiazepine compounds and their use as bile acid modulators

ALBIREO AB28 citations94
US10793534B2Oct 6, 2020

Benzothia(di)azepine compounds and their use as bile acid modulators

ALBIREO AB21 citations94
US10000528B2Jun 19, 2018

IBAT inhibitors for the treatment of liver diseases

ALBIREO AB18 citations94
US10221212B2Mar 5, 2019

IBAT inhibitors for the treatment of liver diseases

ALBIREO AB11 citations92
US12187812B2Jan 7, 2025

IBAT inhibitors for the treatment of liver diseases

ALBIREO AB3 citations86
US11891368B2Feb 6, 2024

Benzothia(di)azepine compounds and their use as bile acid modulators

ALBIREO AB10 citations86
US11708340B2Jul 25, 2023

Benzothia(di)azepine compounds and their use as bile acid modulators

ALBIREO AB12 citations86
US11377429B2Jul 5, 2022

Benzothia(di)azepine compounds and their use as bile acid modulators

ALBIREO AB13 citations86
US11773071B2Oct 3, 2023

Benzothiazepine compounds and their use as bile acid modulators

ALBIREO AB14 citations85
US11603359B2Mar 14, 2023

Benzothiadiazepine compounds and their use as bile acid modulators

ALBIREO AB11 citations85
US11306064B2Apr 19, 2022

Benzothia(di)azepine compounds and their use as bile acid modulators

ALBIREO AB17 citations85
US12365658B2Jul 22, 2025

Benzothia(di)azepine compounds and their use as bile acid modulators

ALBIREO AB2 citations75
US12202809B2Jan 21, 2025

Benzothia(di)azepine compounds and their use as bile acid modulators

ALBIREO AB4 citations75
US12134606B2Nov 5, 2024

Benzothia(di)azepine compounds and their use as bile acid modulators

ALBIREO AB5 citations75
US12060338B2Aug 13, 2024

Benzothia(di)azepine compounds and their use as bile acid modulators

ALBIREO AB5 citations75
US12024495B2Jul 2, 2024

Benzothiazepine compounds and their use as bile acid modulators

ALBIREO AB5 citations75
US12187690B2Jan 7, 2025

Benzothiadiazepine compounds and their use as bile acid modulators

ALBIREO AB4 citations74

ASTRAZENECA AB

16 patents
US7226943B2Jun 5, 2007

Benzothiepine ileal bile acid transport inhibitors

ASTRAZENECA AB80 citations97
US7125864B2Oct 24, 2006

Benzothiazepine derivatives for the treatment of hyperlipidemia

ASTRAZENECA AB86 citations97
US7192946B2Mar 20, 2007

Benzothiazepine derivatives

ASTRAZENECA AB87 citations96
US7238684B2Jul 3, 2007

Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them

ASTRAZENECA AB93 citations95
US7192947B2Mar 20, 2007

Peptides derivatives comprising thiazepine group for the treatment of hyperlipidemic conditions

ASTRAZENECA AB74 citations95
US7192945B2Mar 20, 2007

Benzothiazepine derivatives

ASTRAZENECA AB85 citations95
US7132416B2Nov 7, 2006

Benzothiazepine and benzothiazepine derivatives with ileal bile acid transport (IBAT) inhibotory activity for the treatment hyperlipidaemia

ASTRAZENECA AB90 citations95
US6906058B2Jun 14, 2005

1,5-Benzothiazepines and their use as hypolipidaemics

ASTRAZENECA AB108 citations94
US6518270B1Feb 11, 2003

Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof

ASTRAZENECA AB29 citations92
US6313136B1Nov 6, 2001

Imidazo pyridine derivatives which inhibit gastric acid secretion

ASTRAZENECA AB30 citations92
US6313137B1Nov 6, 2001

Imidazo pyridine derivatives which inhibit gastric acid secretion

ASTRAZENECA AB29 citations92
US6265415B1Jul 24, 2001

Compounds for inhibition of gastric acid secretion

ASTRAZENECA AB18 citations92
US6613775B1Sep 2, 2003

Imidazo[1,2-a]pyridine compounds

ASTRAZENECA AB13 citations83
US6465505B1Oct 15, 2002

Benzyl-substituted benzimidazoles

ASTRAZENECA AB14 citations83
US7470678B2Dec 30, 2008

Diphenylazetidinone derivatives for treating disorders of the lipid metabolism

ASTRAZENECA AB18 citations81
US6579884B1Jun 17, 2003

Compounds

ASTRAZENECA AB11 citations73

STARKE INGEMAR

1 patent

ASTRA AB

1 patent

Showing the top 50 of 58 patents by PatentIndex Score.